Oncotelic Therapeutics Identifies Context-Dependent Biomarkers in Liver and Pancreatic Cancer

Reuters

2025/12/15

Oncotelic <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Identifies Context-Dependent Biomarkers in Liver and Pancreatic Cancer

Oncotelic Therapeutics Inc., in collaboration with the Brush and Key Foundation, has announced the publication of a peer-reviewed research article in the International Journal of Molecular Sciences. The study, titled "Comparative Tumor Microenvironment Analysis for HCC and PDAC Using KMplotter," presents a comprehensive analysis of two emerging biomarkers-DNMT3A and GMPS-in hepatocellular carcinoma $(HCC)$ and pancreatic ductal adenocarcinoma (PDAC). The research, which analyzed data from over 7,000 patients, found that the prognostic significance of these biomarkers is highly context-dependent, influenced by immune composition, metabolic state, and innate immune pathways within the tumor microenvironment. These findings have already been published and highlight the importance of considering tumor context when interpreting biomarkers for cancer prognosis and therapy.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oncotelic Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 9602143) on December 15, 2025, and is solely responsible for the information contained therein.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2591647414"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2591647414\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2591647414?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-15 23:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2591647414","market":"fut","top_or_hot":-1,"title":"Oncotelic Therapeutics Identifies Context-Dependent Biomarkers in Liver and Pancreatic Cancer","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Oncotelic <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Identifies Context-Dependent Biomarkers in Liver and Pancreatic Cancer\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Oncotelic Therapeutics Inc., in collaboration with the Brush and Key Foundation, has announced the publication of a peer-reviewed research article in the International Journal of Molecular Sciences. The study, titled \"Comparative Tumor Microenvironment Analysis for HCC and PDAC Using KMplotter,\" presents a comprehensive analysis of two emerging biomarkers-DNMT3A and GMPS-in hepatocellular carcinoma <a href=\"https://laohu8.com/S/HCC\">$(HCC)$</a> and pancreatic ductal adenocarcinoma (PDAC). The research, which analyzed data from over 7,000 patients, found that the prognostic significance of these biomarkers is highly context-dependent, influenced by immune composition, metabolic state, and innate immune pathways within the tumor microenvironment. These findings have already been published and highlight the importance of considering tumor context when interpreting biomarkers for cancer prognosis and therapy.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oncotelic Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 9602143) on December 15, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Oncotelic Therapeutics Identifies Context-Dependent Biomarkers in Liver and Pancreatic Cancer</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOncotelic Therapeutics Identifies Context-Dependent Biomarkers in Liver and Pancreatic Cancer\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2025-12-15 23:00</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Oncotelic <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Identifies Context-Dependent Biomarkers in Liver and Pancreatic Cancer\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Oncotelic Therapeutics Inc., in collaboration with the Brush and Key Foundation, has announced the publication of a peer-reviewed research article in the International Journal of Molecular Sciences. The study, titled \"Comparative Tumor Microenvironment Analysis for HCC and PDAC Using KMplotter,\" presents a comprehensive analysis of two emerging biomarkers-DNMT3A and GMPS-in hepatocellular carcinoma <a href=\"https://laohu8.com/S/HCC\">$(HCC)$</a> and pancreatic ductal adenocarcinoma (PDAC). The research, which analyzed data from over 7,000 patients, found that the prognostic significance of these biomarkers is highly context-dependent, influenced by immune composition, metabolic state, and innate immune pathways within the tumor microenvironment. These findings have already been published and highlight the importance of considering tumor context when interpreting biomarkers for cancer prognosis and therapy.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oncotelic Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 9602143) on December 15, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IE00B64PRP62.GBP","symbol_name":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (GBP) ACC","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nNDL1xT0dv:1","article_id":"2591647414","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2591647414","pubTimestamp":1765810845,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Oncotelic Therapeutics Inc., in collaboration with the Brush and Key Foundation, has announced the publication of a peer-reviewed research article in the International Journal of Molecular Sciences. The study, titled \"Comparative Tumor Microenvironment Analysis for HCC and PDAC Using KMplotter,\" presents a comprehensive analysis of two emerging biomarkers-DNMT3A and GMPS-in hepatocellular carcinoma  and pancreatic ductal adenocarcinoma . The research, which analyzed data from over 7,000 patients, found that the prognostic significance of these biomarkers is highly context-dependent, influenced by immune composition, metabolic state, and innate immune pathways within the tumor microenvironment. These findings have already been published and highlight the importance of considering tumor context when interpreting biomarkers for cancer prognosis and therapy.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provid","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"IE00B64PRP62.GBP":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (GBP) ACC","LU0314104364.USD":"MANULIFE GF AMERICAN GROWTH \"AA\" (USD) INC","LU2210150020.SGD":"Natixis Thematics Subscription Economy R/A SGD","SG9999014013.SGD":"United Global Durable Equities Fund Dis SGD","LU2210149790.SGD":"Natixis Thematics Subscription Economy R/A SGD-H","SG9999014039.USD":"UNITED GLOBAL DURABLE EQUITIES (USDHDG) INC","NDAQ":"纳斯达克OMX交易所","IE00BKPKM429.USD":"NEUBERGER BERMAN GLOBAL SUSTAINABLE EQUITY \"A\" (USD) ACC","SG9999014005.SGD":"United Global Durable Equities Fund Acc SGD","IE00B3QW5Z07.USD":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (USD) ACC","IE00BGHQF748.EUR":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (EUR) ACC","BK4585":"ETF&股票定投概念","LU2095319765.USD":"Natixis Thematics Subscription Economy R/A USD","BK4588":"碎股","BK4112":"金融交易所和数据","BK4139":"生物科技","SG9999014021.USD":"UNITED GLOBAL DURABLE EQUITIES (USDHDG) ACC","OTLC":"Oncotelic Therapeutics, Inc."},"translate_title":"Oncotelic Therapeutics识别肝癌和胰腺癌中的背景依赖性生物标志物","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OTLC":0.9,"NDAQ":0.9},"content_text":"Oncotelic Therapeutics Identifies Context-Dependent Biomarkers in Liver and Pancreatic Cancer\n    \n\n        Oncotelic Therapeutics Inc., in collaboration with the Brush and Key Foundation, has announced the publication of a peer-reviewed research article in the International Journal of Molecular Sciences. The study, titled \"Comparative Tumor Microenvironment Analysis for HCC and PDAC Using KMplotter,\" presents a comprehensive analysis of two emerging biomarkers-DNMT3A and GMPS-in hepatocellular carcinoma $(HCC)$ and pancreatic ductal adenocarcinoma (PDAC). The research, which analyzed data from over 7,000 patients, found that the prognostic significance of these biomarkers is highly context-dependent, influenced by immune composition, metabolic state, and innate immune pathways within the tumor microenvironment. These findings have already been published and highlight the importance of considering tumor context when interpreting biomarkers for cancer prognosis and therapy.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oncotelic Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 9602143) on December 15, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}